36.04
Finanzdaten der First Tracks Biotherapeutics Inc-Aktie (TRAX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 |
| Periodenlänge | 3 Monate | 3 Monate |
| Operating Expenses |
33.85%
34.94
|
52.81 |
| Operating Income/Loss |
33.85%
-34.94
|
-52.81 |
| Nonoperating Income/Loss |
32.83%
1.563
|
2.327 |
| Net Income/Loss |
33.89%
-33.37
|
-50.48 |
| Basic Average Shares |
35.00
|
- |
| Diluted Average Shares |
35.00
|
- |
| Basic Earnings Per Share |
-0.95
|
- |
| Diluted Earnings Per Share |
-0.95
|
- |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):